2016 Clinical Analytics for PHM Market Trends Report

Join us this today at 1 pm ET/10 am PT for a special, free webinar sponsored by HIStalk. Matt Guldin, lead analyst on our recent Care Management Market Trends report, will be presenting some of the key findings of this

All patients are urged to have a living will, a healthcare proxy, and advanced directives. The latter come in various flavors and spell out the treatment the patient wishes should they become unable to direct their caregivers. The do-not-resuscitate (DNR)

Much of the rhetoric surrounding healthcare innovation is happy. Smiling young people run along a river on a sunny day, then check their FitBits. Smiling parents hold iPads while they connect to a smiling pediatrician over video chat. Smiling nurses

Coming out of HIMSS 2016 I was struck by the sheer number of Population Health Management offerings. There are a myriad of vendors offering a multitude of data analytics offerings for providers and payers navigating the new waters of value-based

I’ll probably catch a lot of heat for this post, but this has to be said. It is time to accept that the patient portal, as currently architected, is a complete dead-end. Our national efforts to promote patient portals through

By now you’ve probably seen the Health Affairs study (and requisite mainstream media coverage) stipulating that retail health clinics actually add to the nation’s healthcare spending by encouraging the use of medical services. The study is not without merit, but

The pilgrimage to HIMSS has once again come to pass. While certainly not a spiritual pilgrimage – after all it did take place in Sin City – it is a trek into the depths of healthcare IT (HIT). No other

With the completion and release of the Care Management Market Trends Report last week, I arrived out in sunny and warm Las Vegas for the HIMSS16 Conference. I just wanted to post a brief list of things I will be

Chilmark Research launched the Care Coordination domain (now Care Management) in an effort to bring clarity to a diverse and emerging market that had yet to be subject to formal, in-depth analysis. Dozens of vendors from all over the health

Earlier this month, Zenefits joined Theranos and 23andMe on the list of Silicon Valley startups to run afoul of regulators. Some commentators refer to the situation at large as Silicon Valley’s Waterloo. The headline is certainly catchy – especially for

Analytics

Care Coordination

Clinician Network Management

Patient Engagement